Apoptosis, or programmed cell death, is a complex network of biochemical pathways for controlling such events in a cell. Apoptosis is essential, as its failure can lead to disease. Because apoptosis concerns the regulation of sequential events, including the removal of inflammatory cells and the evolution of granulation tissue into scar tissue, it has an essential role in wound repair. This article examines the literature and proposes that apoptosis features in the development of diabetic foot wounds. Hyperglycemia deregulates the sequential apoptotic events by multiple mechanisms, leading to delayed wound healing. Deregulated apoptosis is emerging as a prominent cause of delayed wound healing, especially in diabetic wounds, along with the well-known triad of peripheral vascular disease, neuropathy, and infection.
Desmouliere A, Redard M, Darby I, et al.Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol1995;146:56-66.
2.
Walker NI, Harmon BV, Gobe GC, et al.Patterns of cell death. Methods Achiev Exp Pathol1988;13:18-54.
3.
Schwartzman RA, Cidlowski JA. Apoptosis: the biochemistry and molecular biology of programmed cell death. Endocr Rev1993;14:133-151.
4.
Wyllie AH, Kerr JF, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol1980;68:251-306.
5.
Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science1995;267:1456-1462.
6.
Evans R, Cidlowski JA. Apoptosis: cellular signaling and molecular mechanisms. In: Oliver C, editors. Cell Biology of Trauma. Boston, MA: CRC Press; 1995. p. 25-47.
7.
Cotran RS, Kumar V, Collins T. Robbin’s pathological basic of disease. 6th ed.Philadelphia, PA: W. B. Saunders Co; 1999.
8.
Au JL, Panchal N, Li D, et al.Apoptosis: a new pharmacodynamic endpoint. Pharm Res1997;14:1659-1671.
9.
Teraki Y, Shiohara T. Apoptosis and the skin. Eur J Dermatol1999;9:413-425; quiz 426.
10.
Al-Rubeai M, Singh RP. Apoptosis in cell culture. Curr Opin Biotechnol1998;9:152-156.
11.
Yang E, Korsmeyer SJ. Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood1996;88:386-401.
12.
Costa AM, Peyrol S, Porto LC, Comparin JP, Foyatier JL, Desmouliere A. Mechanical forces induce scar remodeling: study in non-pressure-treated versus pressure-treated hypertrophic scars. Am J Pathol1999;155:1671-1679.
13.
Hale AJ, Smith CA, Sutherland LC, et al.Apoptosis: molecular regulation of cell death. Eur J Biochem1996;236:1-26.
14.
Bellamy CO, Malcomson RD, Harrison DJ, et al.Cell death in health and disease: the biology and regulation of apoptosis. Semin Cancer Biol1995;6:3-16.
15.
Schwartzman RA, Cidlowski JA. Glucocorticoid-induced apoptosis of lymphoid cells. Int Arch Allergy Immunol1994;105: 347-354.
16.
Salvesen GS, Dixit VM. Caspases: intracellular signaling by proteolysis. Cell1997;91:443-446.
17.
Roth KA. Caspases, apoptosis, and Alzheimer’s disease: causation, correlation, and confusion. J Neuropathol Exp Neurol2001;60:829-838.
18.
Marshman E, Ottewell PD, Potten CS, et al.Caspase activation during spontaneous and radiation-induced apoptosis in the murine intestine. J Pathol2001;195:285-292.
19.
Clerk A, Cole SM, Cullingford TE, et al.Regulation of cardiac myocyte cell death. Pharmacol Ther2003;97:223-261.
20.
Hay BA. Understanding IAP function and regulation: a view from Drosophila. Cell Death Differ2000;7:1045-1056.
21.
Roy N, Mahadevan MS, McLean M, et al.The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell1995;80:167-178.
22.
Deveraux QL, Takahashi R, Salvesen GS, et al.X-linked IAP is a direct inhibitor of cell-death proteases. Nature1997;388:300-304.
23.
Deveraux QL, Reed JC. IAP family proteins: suppressors of apoptosis. Genes Dev1999;13:239-252.
24.
Cheng EH, Levine B, Boise LH, et al.Bax-independent inhibition of apoptosis by Bcl-XL. Nature1996;379:554-556.
25.
Cameron R, Feuer G. Molecular cellular and tissue reactions of apoptosis and their modulation by drugs. In: Feuer G, editor. Handbook of Experimental Pharmacology. New York: Springer; 2000. p. 38-57.
26.
Levine AJ. p53, the cellular gatekeeper for growth and division. Cell1997;88:323-331.
27.
Lane DP. Cancer: p53, guardian of the genome. Nature1992;358:15-16.
28.
Blatt NB, Glick GD. Signaling pathways and effector mechanisms pre-programmed cell death. Bioorg Med Chem2001;9:1371-1384.
29.
Itoh N, Yonehara S, Ishii A, et al.The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell1991;66:233-243.
30.
Oehm A, Behrmann I, Falk W, et al.Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily: sequence identity with the Fas antigen. J Biol Chem1992;267:10709-10715.
31.
Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer1972;26:239-257.
32.
Fadeel B, Orrenius S, Zhivotovsky B. Apoptosis in human disease: a new skin for the old ceremony?Biochem Biophys Res Commun1999;266:699-717.
33.
Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell1995;80:293-299.
34.
Owen-Schaub LB, Zhang W, Cusack JC, et al.Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol Cell Biol1995;15:3032-3040.
35.
Park DS, Stefanis L, Greene LA. Ordering the multiple pathways of apoptosis. Trends Cardiovasc Med1997;7:294-299.
36.
Roberts AB, Sporn MB. Physiological actions and clinical applications of transforming growth factor-β. Growth Factors. 1993;8:1-9.
37.
NemesZ Jr, Friis RR, Aeschlimann D, Saurer S, Paulsson M, Fesus L. Expression and activation of tissue transglutaminase in apoptotic cells of involuting rodent mammary tissue. Eur J Cell Biol1996;70:125-133.
38.
Bortner CD, Oldenburg ND, Cidlowski JA. The role of DNA fragmentation in apoptosis. Trends Cell Biol1995;5:21-26.
39.
McCarthy NJ, Evan GI. Methods of detecting and quantifying apoptosis. Curr Top Dev Biol1998;36:259-278.
40.
Dong Z, Saikumar P, Weinberg JM, Venkatachalam MA, et al.Internucleosomal DNA cleavage triggered by plasma membrane damage during necrotic cell death: involvement of serine but not cysteine proteases. Am J Pathol1997;151:1205-1213.
41.
Savill J.Recognition and phagocytosis of cells undergoing apoptosis. Br Med Bull1997;53:491-508.
42.
Ohata H, Yatomi Y, Sweeney EA, et al.A possible role of sphinogosine in induction of apoptosis by tumor necrosis factor-α in human neutrophils. FEBS Lett1994;355:267-270.
43.
Walzog B, Jeblonski F, Zakrzewicz A, Gaehtgens P. 2 integrins promote apoptosis of human neutrophils. FASEB J.1997;11:1177-1186.
44.
Tidball JG, St Pierre BA. Apoptosis of macrophages during the resolution of muscle inflammation. J Leukoc Biol1996;59:380-388.
45.
Antoniades HN, Galanopoulos T, Neville-Golden J, Kiritsy CP, Lynch SE. P53 expression during normal tissue regeneration in response to acute cutaneous injury in sweine. J Clin Invest1994; 93:2206-2214.
46.
Compton CC, Gill JM, Bradford DA, Regauer S, Gallico CG, O’Conner NE. Skin regenerated from cultured epithelial autografts on full-thickness burn wounds from 6 days to 5 years after grafting. A light, electron microscope and immunohistochemical study. Lab Invest1989;60:600-612.
47.
Green DR, A Myc-induced apoptosis pathway surfaces. Science1997;278:1246-1247.
48.
Hueber AO, Zornig M, Lyon D, Suda T, Nagata, Evan GI. Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis. Science1997;278:1305-1309.
49.
Bian J, Sun Y. Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter. Mol Cell Biol1997;17:6330-6338.
50.
Darby IA, Bisucci T, Pittet B, Garbin S, Gabbani G, Desmouliere A. Skin flap-induced regression of granulation tissue correlates with reduced growth factor and increased metalloproteinase expression. J Pathol2002;197(1): 117-127.
51.
LoGerfo FW, Coffman JD. Vascular and microvascular disease of the foot in diabetes: implication for foot care. N Engl J Med1984;311:1615-1619.
52.
Ferguson MWJ, Herrick SE, Spencer MJ, Show JE, Boulton AJM, Sloan P. The histology of diabetic foot ulcer. Diabetic Med1996;13:S30-S33.
53.
Vlasara H, Bucala R, Striker L. Pathogenic effects of advanced glycosylation biodrenical biologic and clinical implication for diabetes and aging. Lab Invest1994;76;138-151.
54.
Yamamoto T, Nakamara T, Noble NA, Ruoslahti E, Border WA. Expression of transforming growth factor B is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci USA1993;90:1814-1818.
55.
Darby IA, Shalli O, Gabbiani G. α smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab Invest1990;63:21-29.
56.
Darby IA, Biscucci T, Hewitson TD, McLellan DG. Apoptosis is increased in a genetically diabetic impaired wound healing in genetically diabetic mice. Int J Biochem Cell Biot1997;29:191-200.
57.
Baumgartner-Parzer SM, Ludwig W, Deffermann M, Grillari J, Gessl A, Waldhausl W. High glucose-triggered apoptosis in cultured endothelial cells. Diabetes1995;44:1323-1327.
58.
Baynes JW, Thorpe SR, Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes1999; 48:1-9.
59.
Cai L, Li W, Wang G, Guo L, Jiang Y, Kanj YJ. Hyperglycemia induced apoptosis in mouse myocardium mitochondrial cytochrome C-mediated caspase-3 activation pathway. Diabetes2002;51:1938-1948.
60.
Ido Y, Carling D, Ruderman N. Hyperglycemia-induced apoptosis in human umbilical vein endothelial cells. Diabetes2002;51:159-167.
61.
Datta SR, Brunef A, Greenberg ME. Cellular survival: a play in three Akts. Genes Dev1999;13:2905-2927.
62.
Risso A, Mercuri F, Quagliaro L, Damante G, Ceriello A. Intermittent high glucose enhances apoptosis in human umbilical ion endothelial cells in culture. Am J Physiol End Crinol Metab2001;281:E924-E930.
63.
Rai NK, Suryabhan, Ansari M, Kumar M, Shukla VK, Tripathi K. Effect of glycaemic control on apoptosis in diabetic wounds. J Wound Care2005;14:277-281.
